DK1159974T3
(da)
|
1993-07-19 |
2007-11-26 |
Angiotech Pharm Inc |
Antiangiogene sammensætninger indeholdende taxol og en ikke-bionedbrydelig bærer og deres anvendelse
|
US5716981A
(en)
*
|
1993-07-19 |
1998-02-10 |
Angiogenesis Technologies, Inc. |
Anti-angiogenic compositions and methods of use
|
US5681846A
(en)
*
|
1995-03-17 |
1997-10-28 |
Board Of Regents, The University Of Texas System |
Extended stability formulations for paclitaxel
|
US6964946B1
(en)
|
1995-10-26 |
2005-11-15 |
Baker Norton Pharmaceuticals, Inc. |
Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
|
US6395770B1
(en)
|
1995-10-26 |
2002-05-28 |
Baker Norton Pharmaceuticals, Inc. |
Method and compositions for administering taxanes orally to human patients
|
US6245805B1
(en)
*
|
1995-10-26 |
2001-06-12 |
Baker Norton Pharmaceuticals, Inc. |
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
|
CN1209059A
(zh)
*
|
1995-12-21 |
1999-02-24 |
基因实验室技术有限公司 |
紫杉烷类组合物及方法
|
KR100191446B1
(ko)
*
|
1996-05-02 |
1999-06-15 |
송영욱 |
파클리탁셀 함유 전신성 홍반성 낭창치료제
|
WO1997045105A1
(en)
*
|
1996-05-24 |
1997-12-04 |
Angiotech Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing diseases of body passageways
|
KR100330373B1
(ko)
*
|
1996-05-28 |
2002-11-07 |
주식회사한국신약 |
탁솔을 함유한 주사용 약제 조성물
|
US5877205A
(en)
*
|
1996-06-28 |
1999-03-02 |
Board Of Regents, The University Of Texas System |
Parenteral paclitaxel in a stable non-toxic formulation
|
KR100358934B1
(ko)
*
|
1996-09-13 |
2003-01-29 |
주식회사한국신약 |
탁솔을함유한주사용약제조성물
|
US6515016B2
(en)
|
1996-12-02 |
2003-02-04 |
Angiotech Pharmaceuticals, Inc. |
Composition and methods of paclitaxel for treating psoriasis
|
CA2628857C
(en)
*
|
1996-12-30 |
2011-09-13 |
Batelle Memorial Institute |
Formulation and method for treating neoplasms by inhalation
|
CA2288306A1
(en)
|
1997-04-28 |
1998-11-05 |
Rhone-Poulenc Rorer S.A. |
Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
|
CN1101677C
(zh)
*
|
1997-05-30 |
2003-02-19 |
韩万愚 |
含有紫杉醇的药用注射溶液
|
EP0998279B1
(de)
*
|
1997-05-30 |
2002-10-16 |
Man Woo Han |
Taxol enthaltende pharmazeutische injektionslösung
|
BE1011216A3
(fr)
*
|
1997-06-13 |
1999-06-01 |
Thissen En Abrege L T B Lab |
Forme pharmaceutique pour l'administration de paclitaxel, procede de preparation d'une composition de paclitaxel prete a l'emploi et utilisation de cette composition.
|
US5925776A
(en)
*
|
1997-12-24 |
1999-07-20 |
Schein Pharmacetical, Inc. |
Polyethoxylated castor oil, process of making the same and formulations thereof
|
GB9803448D0
(en)
*
|
1998-02-18 |
1998-04-15 |
Pharma Mar Sa |
Pharmaceutical formulation
|
US5922754A
(en)
*
|
1998-10-02 |
1999-07-13 |
Abbott Laboratories |
Pharmaceutical compositions containing paclitaxel
|
US6071952A
(en)
*
|
1998-12-02 |
2000-06-06 |
Mylan Pharmaceuticals, Inc. |
Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
|
FR2794771B1
(fr)
|
1999-06-11 |
2001-08-10 |
Aventis Pharma Sa |
Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
|
AU775373B2
(en)
|
1999-10-01 |
2004-07-29 |
Immunogen, Inc. |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
|
NZ518847A
(en)
*
|
1999-11-15 |
2004-02-27 |
Pharma Mar S |
Aplidine treatment of cancers
|
CZ20013498A3
(cs)
*
|
2000-02-02 |
2002-04-17 |
Florida State University Research Foundation, Inc. |
Taxanové formulace mající zlepąenou rozpustnost
|
KR20010100194A
(ko)
*
|
2000-03-13 |
2001-11-14 |
박호군 |
여러 가지 물질의 가용화용 조성물과 제형 및 그들의제조방법
|
WO2002043765A2
(en)
*
|
2000-11-28 |
2002-06-06 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
|
EP1435908A4
(de)
*
|
2001-09-13 |
2006-03-15 |
Korea Inst Sci & Tech |
Ölige paclitaxel-zusammensetzung und formulierung für die chemoembolisation und herstellungsverfahren dafür
|
EP1435991B1
(de)
*
|
2001-10-19 |
2008-10-15 |
Pharma Mar, S.A. |
Verwendung von aplidine in der behandlung von pankreaskrebs
|
WO2003045357A1
(en)
*
|
2001-11-27 |
2003-06-05 |
Transform Pharmaceuticals, Inc. |
Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
|
US8313760B2
(en)
|
2002-05-24 |
2012-11-20 |
Angiotech International Ag |
Compositions and methods for coating medical implants
|
CN100341589C
(zh)
|
2002-05-24 |
2007-10-10 |
血管技术国际股份公司 |
用于涂覆医用植入物的组合物和方法
|
PT1534340E
(pt)
|
2002-09-06 |
2012-03-13 |
Cerulean Pharma Inc |
Polímeros à base de ciclodextrina para a administração de medicamentos ligados por ligação covalente
|
US20080220074A1
(en)
*
|
2002-10-04 |
2008-09-11 |
Elan Corporation Plc |
Gamma radiation sterilized nanoparticulate docetaxel compositions and methods of making same
|
WO2006055008A2
(en)
*
|
2003-11-20 |
2006-05-26 |
Angiotech International Ag |
Implantable sensors and implantable pumps and anti-scarring agents
|
AU2005285953B2
(en)
|
2004-09-22 |
2011-01-20 |
Nippon Kayaku Kabushiki Kaisha |
Novel block copolymer, micelle preparation, and anticancer agent containing the same as active ingredient
|
AU2005100176A4
(en)
*
|
2005-03-01 |
2005-04-07 |
Gym Tv Pty Ltd |
Garbage bin clip
|
EP2308467A3
(de)
|
2005-06-17 |
2011-06-22 |
Hospira Australia Pty Ltd |
Flüssige Pharmazeutische Docetaxel Zubereitungen
|
GB0517092D0
(en)
*
|
2005-08-19 |
2005-09-28 |
Novartis Ag |
New compositions containing taxane derivatives
|
AR054215A1
(es)
*
|
2006-01-20 |
2007-06-13 |
Eriochem Sa |
Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit
|
BRPI0600194A
(pt)
|
2006-01-30 |
2007-10-23 |
Quiral Quimica Do Brasil S A |
composições farmacêuticas contendo docetaxel e um inibidor de degradação e processo de obtenção das mesmas
|
CN101023940A
(zh)
*
|
2006-02-20 |
2007-08-29 |
郝守祝 |
一种紫杉烷类化合物的药用组合物、制备方法及用途
|
KR20080106254A
(ko)
*
|
2006-03-28 |
2008-12-04 |
니폰 가야꾸 가부시끼가이샤 |
탁산류의 고분자 결합체
|
WO2007135910A1
(ja)
|
2006-05-18 |
2007-11-29 |
Nippon Kayaku Kabushiki Kaisha |
ポドフィロトキシン類の高分子結合体
|
CA2664852A1
(en)
*
|
2006-10-03 |
2008-04-10 |
Nippon Kayaku Kabushiki Kaisha |
High-molecular weight conjugate of resorcinol derivatives
|
US8334364B2
(en)
|
2006-11-06 |
2012-12-18 |
Nipon Kayaku Kabushiki Kaisha |
High-molecular weight derivative of nucleic acid antimetabolite
|
EP2090607B1
(de)
|
2006-11-08 |
2015-05-20 |
Nippon Kayaku Kabushiki Kaisha |
Polymerderivat eines nukleinsäuremetabolismus-antagonisten
|
ATE525484T1
(de)
|
2007-01-08 |
2011-10-15 |
Us Gov Health & Human Serv |
Slco1b3-genotyp
|
CZ200756A3
(cs)
*
|
2007-01-23 |
2008-07-30 |
Heaton, A. S. |
Dvousložková farmaceutická kompozice obsahující taxan
|
JP2010516625A
(ja)
|
2007-01-24 |
2010-05-20 |
インサート セラピューティクス, インコーポレイテッド |
制御された薬物送達のためのテザー基を有するポリマー−薬物コンジュゲート
|
CN101244053B
(zh)
*
|
2007-02-16 |
2010-12-08 |
石药集团中奇制药技术(石家庄)有限公司 |
以多西他赛为主组分的新的分散体系
|
CA2683712A1
(en)
*
|
2007-04-20 |
2009-01-15 |
Sun Pharmaceutical Industries Limited |
Pharmaceutical compositions
|
KR20100023862A
(ko)
*
|
2007-06-22 |
2010-03-04 |
싸이도우스 엘엘씨. |
트윈 80을 함유하지 않은 도세탁셀의 용해 제제
|
WO2009041570A1
(ja)
*
|
2007-09-28 |
2009-04-02 |
Nippon Kayaku Kabushiki Kaisha |
ステロイド類の高分子結合体
|
CN101396354B
(zh)
*
|
2007-09-30 |
2010-12-01 |
江苏恒瑞医药股份有限公司 |
一种稳定的塔三烷类化合物液体组合物及其制备方法和其应用
|
EP2205215A2
(de)
*
|
2007-10-01 |
2010-07-14 |
Intas Pharmaceuticals Limited |
Absolut ethanolfreie injizierbare docetaxelzusammensetzung
|
AR063111A1
(es)
*
|
2007-10-03 |
2008-12-30 |
Eriochem Sa |
Una formulacion farmaceutica de taxano
|
FR2922107B1
(fr)
*
|
2007-10-10 |
2010-02-26 |
Aventis Pharma Sa |
Nouvelles compositions a base de taxoides
|
JP5694782B2
(ja)
|
2008-03-14 |
2015-04-01 |
バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド |
肺癌、腺癌及び他の病状のための治療方法及び組成物
|
WO2009113989A1
(en)
|
2008-03-14 |
2009-09-17 |
Bionumerik Pharmaceuticals, Inc. |
Compositions and methods of use of compounds to increase cancer patient survival time
|
CA3146422A1
(en)
|
2008-03-18 |
2009-09-24 |
Genentech, Inc. |
Combinations of an anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of use
|
US8920788B2
(en)
*
|
2008-03-18 |
2014-12-30 |
Nippon Kayaku Kabushiki Kaisha |
High-molecular weight conjugate of physiologically active substances
|
EP2284209B1
(de)
|
2008-05-08 |
2016-08-31 |
Nippon Kayaku Kabushiki Kaisha |
Polymerkonjugat aus folsäure oder einem folsäurederivat
|
ES2344674B1
(es)
|
2008-08-07 |
2011-06-29 |
Gp Pharm, S.A. |
Composicion farmaceutica inyectable de taxanos.
|
CA2732508C
(en)
|
2008-08-11 |
2016-03-15 |
Nektar Therapeutics |
Multi-arm polymeric alkanoate conjugates
|
US8541360B2
(en)
*
|
2008-11-19 |
2013-09-24 |
Ben Venue Laboratories, Inc. |
Parenteral formulations comprising sugar-based esters and ethers
|
MX2011009413A
(es)
|
2009-03-11 |
2011-10-21 |
Ambit Biosciences Corp |
Combinacion de una indazolilaminopirrolotriazina y taxano para tratamiento contra cancer.
|
CN102421827B
(zh)
|
2009-05-15 |
2014-07-30 |
日本化药株式会社 |
具有羟基的生理活性物质的高分子结合体
|
US20110092579A1
(en)
*
|
2009-10-19 |
2011-04-21 |
Scidose Llc |
Solubilized formulation of docetaxel
|
US7772274B1
(en)
|
2009-10-19 |
2010-08-10 |
Scidose, Llc |
Docetaxel formulations with lipoic acid
|
US8476310B2
(en)
|
2009-10-19 |
2013-07-02 |
Scidose Llc |
Docetaxel formulations with lipoic acid
|
US8912228B2
(en)
|
2009-10-19 |
2014-12-16 |
Scidose Llc |
Docetaxel formulations with lipoic acid
|
US8541465B2
(en)
*
|
2009-10-19 |
2013-09-24 |
Scidose, Llc |
Docetaxel formulations with lipoic acid and/or dihydrolipoic acid
|
CA2779009A1
(en)
|
2009-10-29 |
2011-05-05 |
Aventis Pharma S.A. |
Novel antitumoral use of cabazitaxel
|
JP6220126B2
(ja)
*
|
2009-11-23 |
2017-10-25 |
セルリアン・ファーマ・インコーポレイテッド |
治療的送達のためのシクロデキストリンに基づく重合体
|
AR079256A1
(es)
|
2009-12-04 |
2012-01-04 |
Genentech Inc |
Metodo para el tratamiento del cancer de mama metastasico con trastuzumab-mcc-dm1
|
KR20120111739A
(ko)
|
2009-12-31 |
2012-10-10 |
센트로 내셔널 드 인베스티가시오네스 온콜로지카스 (씨엔아이오) |
키나제 억제제로서의 사용을 위한 삼환식 화합물
|
WO2011089400A1
(en)
|
2010-01-22 |
2011-07-28 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
Inhibitors of pi3 kinase
|
CA2790176A1
(en)
|
2010-02-18 |
2011-08-25 |
Centro Nacional De Investigaciones Oncologicas (Cnio) |
Triazolo [4, 5 - b] pyridin derivatives
|
TWI438009B
(zh)
*
|
2010-02-19 |
2014-05-21 |
Teikoku Pharma Usa Inc |
紫杉烷前-乳劑調配物及其製造與使用之方法
|
WO2011121317A1
(en)
|
2010-04-01 |
2011-10-06 |
Centro Nacional De Investigaciones Oncologicas (Cnio) |
Imidazo [2,1-b] [1,3,4] thiadiazoles as protein or lipid kinase inhibitors
|
KR101752944B1
(ko)
|
2010-05-03 |
2017-07-03 |
테이코쿠 팔마 유에스에이, 인코포레이티드 |
비수성의 탁산 프로에멀젼 제제, 및 그의 제조 및 사용 방법
|
WO2012052745A1
(en)
|
2010-10-21 |
2012-04-26 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
Combinations of pi3k inhibitors with a second anti -tumor agent
|
KR20140024833A
(ko)
|
2010-11-17 |
2014-03-03 |
니폰 가야꾸 가부시끼가이샤 |
신규한 시티딘계 대사길항제의 고분자 유도체
|
WO2012088445A1
(en)
|
2010-12-22 |
2012-06-28 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
|
WO2012088422A1
(en)
|
2010-12-22 |
2012-06-28 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of taxane-based compounds
|
EP2694072B1
(de)
|
2011-04-01 |
2017-11-29 |
Genentech, Inc. |
Kombination von akt-hemmer-verbindung und abirateron zur verwendung in therapeutischen verfahren
|
WO2012156999A1
(en)
|
2011-05-19 |
2012-11-22 |
Manu Chaudhary |
Ready to use docetaxel formulation
|
EP2524918A1
(de)
|
2011-05-19 |
2012-11-21 |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Imidazopyrazinderivate als Kinase Inhibitoren
|
WO2012156756A2
(en)
|
2011-05-19 |
2012-11-22 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
New compounds
|
WO2013005057A1
(en)
|
2011-07-07 |
2013-01-10 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
New compounds
|
WO2013005041A1
(en)
|
2011-07-07 |
2013-01-10 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
Tricyclic heterocyclic compounds as kinase inhibitors
|
WO2013004984A1
(en)
|
2011-07-07 |
2013-01-10 |
Centro Nacional De Investigaciones Oncologicas (Cnio) |
Tricyclic compounds for use as kinase inhibitors
|
EP2753355B1
(de)
|
2011-09-08 |
2018-10-24 |
New York University |
Onkolytisches herpes-simplex-virus und therapeutische verwendungen davon
|
RU2623426C2
(ru)
|
2011-09-11 |
2017-06-26 |
Ниппон Каяку Кабусики Кайся |
Способ получения блок-сополимера
|
WO2013096455A1
(en)
|
2011-12-20 |
2013-06-27 |
Dana-Farber Cancer Institute, Inc. |
Methods for diagnosing and treating oncogenic kras-associated cancer
|
WO2013130093A1
(en)
|
2012-03-02 |
2013-09-06 |
Genentech, Inc. |
Biomarkers for treatment with anti-tubulin chemotherapeutic compounds
|
EP2855698A4
(de)
|
2012-05-24 |
2016-03-30 |
Dana Farber Cancer Inst Inc |
Abzielung auf den glutamin-zu-pyruvat-signalweg zur behandlung von mit dem kras-onkogen assoziierten krebs
|
KR101909801B1
(ko)
|
2012-06-08 |
2018-10-18 |
에프. 호프만-라 로슈 아게 |
암의 치료를 위한 포스포이노시타이드 3 키나제 억제제 화합물 및 화학치료제의 돌연변이체 선택성 및 조합물
|
US20150285802A1
(en)
|
2012-07-18 |
2015-10-08 |
Dana-Farber Cancer Institute, Inc. |
Methods for treating, preventing and predicting risk of developing breast cancer
|
JO3685B1
(ar)
|
2012-10-01 |
2020-08-27 |
Teikoku Pharma Usa Inc |
صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
|
WO2014055493A1
(en)
|
2012-10-02 |
2014-04-10 |
Cerulean Pharma Inc. |
Methods and systems for polymer precipitation and generation of particles
|
WO2014149871A1
(en)
|
2013-03-14 |
2014-09-25 |
Icahn School Of Medicine At Mount Sinai |
Autologous tumor lysate-loaded dendritic cell vaccine for treatment of liver cancer
|
WO2015050844A1
(en)
|
2013-10-01 |
2015-04-09 |
Dana-Farber Cancer Institute, Inc. |
Methods of treating cancer with atovaquone-related compounds
|
PE20211798A1
(es)
|
2014-03-21 |
2021-09-13 |
Abbvie Inc |
Anticuerpos y conjugados de anticuerpo y farmaco anti-egfr
|
WO2015149006A2
(en)
|
2014-03-27 |
2015-10-01 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating ncoa4-mediated autophagic targeting of ferritin
|
MA39818A
(fr)
|
2014-03-30 |
2017-02-08 |
Benevir Biopharm Inc |
Virus oncolytiques « armés » comprenant un inhibiteur de tap exogène et leurs utilisations thérapeutiques
|
EP3307330B1
(de)
|
2015-06-15 |
2021-03-10 |
New York University |
Verfahren zur behandlung unter verwendung onkolytischer viren
|
US10188626B2
(en)
|
2015-11-03 |
2019-01-29 |
Cipla Limited |
Stabilized cabazitaxel formulations
|
BR112018075653A2
(pt)
|
2016-06-08 |
2019-08-27 |
Abbvie Inc |
anticorpos anti-b7-h3 e conjugados anticorpo fármaco
|
CN109562169A
(zh)
|
2016-06-08 |
2019-04-02 |
艾伯维公司 |
抗cd98抗体及抗体药物偶联物
|
MX2018015272A
(es)
|
2016-06-08 |
2019-08-12 |
Abbvie Inc |
Anticuerpos anti-cd98 y conjugados de anticuerpo y farmaco.
|
CN116284404A
(zh)
|
2016-06-08 |
2023-06-23 |
艾伯维公司 |
抗b7-h3抗体和抗体药物偶联物
|
JP2019521973A
(ja)
|
2016-06-08 |
2019-08-08 |
アッヴィ・インコーポレイテッド |
抗bh7−h3抗体及び抗体薬物コンジュゲート
|
AU2018328532A1
(en)
|
2017-09-07 |
2020-04-23 |
Ningbo Combireg Pharmaceutical Technology Co., Ltd |
Pharmaceutical composition of docetaxel conjugate and preparation method
|
AR124681A1
(es)
|
2021-01-20 |
2023-04-26 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|